DeviceTalks Weekly

DeviceTalks Podcast Network
  • 0.0（0）
  • テクノロジー
  • アップデート：毎週

Hosted by Tom Salemi, DeviceTalks Weekly is the foundational podcast for the entire DeviceTalks Podcast Network. The series delivers weekly news, insights, and commentary from MedTech industry leaders, keeping the medical device industry in the know and inspiring medical technology professionals to build better MedTech devices and companies.

  1. 8月21日

    Ep 302 - Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage

    In this podcast episode, Tito Porras, MD, MBA, CEO and co-founder of startup Inner Logic, shares his unusual path to MedTech entrepreneurship with Host Tom Salemi. Dr. Porras was training to become a neurosurgeon at Johns Hopkins when he began questioning the limits of surgeon training. He realized that even better training wouldn't solve the larger problem: there aren't enough surgeons to provide the care patients need. That realization eventually led Porras to entrepreneurship and Inner Logic, which is developing intelligence and simulation infrastructure that can help develop devices with greater autonomy. Porras explains the difference between automation and autonomy, how AI can help devices perceive and adapt to what's happening during a procedure, and why this technology could eventually expand access to surgical care. Dr. Porras also discusses Inner Logic's work with virtual patients and synthetic data, the potential for autonomy across endovascular, orthopedic and surgical applications, and why the future of autonomous surgery will likely arrive through a series of incremental steps rather than one dramatic leap. MassDevice Editor Chris Newmarker kicks off the podcast with Newmarker's Newsmakers, covering the FDA, Haemonetics, Senseonics, Johnson & Johnson MedTech and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:15) - Trump nominates policy aide as next FDA commissioner(00:09:28) - Haemonetics reconnects with CSL in US plasma collection deal(00:13:22) - Senseonics sees activist investor take a major stake(00:16:08) - Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software(00:17:45) - Medtronic faces potential injunction in Applied Medical case(00:22:26) - Keynote Interview – Tito Porras, MD, CEO and Co-Founder of Inner Logic

    Ep 302 - Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage

  2. 8月14日

    Ep 301 - Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio

    In this episode of DeviceTalks Weekly, Host Tom Salemi welcomes Kendra Grubb, MD, vice president and chief medical officer of Medtronic’s Structural Heart business. Dr. Grubb fulfilled her childhood ambition of becoming a cardiac surgeon and an interventionalist. In this episode, Dr. Grubb discusses how structural heart has transformed over the past two decades and why she believes the field is approaching another major disruption. She explores the future of transcatheter therapies, the growing role of AI, imaging and robotics, the challenge of treating more patients, and how Medtronic is building a broader structural heart portfolio. Dr. Grubb also shares her unusual journey from cardiac surgeon and academic leader to medtech executive and explains why she believes the next generation of structural heart technology must make advanced therapies more accessible to more patients. This episode is sponsored by Cortland Biomedical. Go to https://www.cortlandbiomedical.com/ to see their work in the structural heart space. MassDevice Editor Chris Newmarker delivers this week’s Newmarker’s Newsmakers – Alcon, Intuitive, Cook Medical, CVRx, and GE HealthCare. To register for Medical Design & Outsourcing’s Min-Vasive MedTech Webinar Series, go here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415899/medical-design-outsourcing. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

    Ep 301 - Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio

  3. 8月7日

    Ep 300 - How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise

    In this episode of the DeviceTalks Weekly podcast, Mobia Medical CEO Richard Foust explains how the “magical” qualities of the company's neurotechnology helped steer it toward an IPO. Mobia Medical’s implantable pulse generator promotes motor skill recovery in patients who have suffered a stroke. The company’s early commercial success has generated modest revenue, but Foust tells host Tom Salemi that “not all revenue is the same,” explaining why a large, untapped and growing market won over venture capital investors a few years ago and public investors this spring. MassDevice Editor Chris Newmarker returns with another edition of Newmarker’s Newsmakers. Tom and Chris repeatedly lament the departure of former Senior Editor Sean Whooley, who recently left MassDevice to pursue other opportunities. Despite his departure, Sean’s reporting remains front and center, as he wrote all five featured stories covering Danaher, Medtronic, Boston Scientific, Integer, Teleflex, and private equity investors. Special thanks to our sponsors of MassDevice’s Diabetes Technology Innovations Special Report: Cadence, Jabil, and Viant Medical! Download the complimentary report here: https://www.massdevice.com/diabetes-technology-innovations-special-report-2026/ *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

    Ep 300 - How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise

  4. 7月31日

    Ep 299 - Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller

    In this episode of the DeviceTalks Weekly podcast, we tackle a range of topics related to the surgical robotics industry. In our keynote conversation, Brian Miller, formerly of Intuitive and now CEO of Sovato, discusses the potential of telesurgery, a promising capability of surgical robotic systems that could save lives while reducing costs and improving efficiency across the healthcare system. In our FOMO interview, Christy Gaudet, global head of solutions at Karl Storz, explains the company's decision to discontinue the Asensus Surgical robotics systems and focus on the often under-appreciated art of imaging. Finally, surgical robotics expert Steve Bell shares his top five newsmakers from the Society of Robotic Surgery (SRS) Annual Meeting, including Ottava, AI, and humanoid surgical robots. Host Tom Salemi also interviews Jim Leonard, vice president of sales at Harmonic Drive, the sponsor of this episode. Visit http://HarmonicDrive.net for more information. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

  5. 7月24日

    Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi is joined by Harith Rajagopalan, MD, PhD, co-founder and CEO of Fractyl Health. Dr. Rajagopalan explains why Fractyl shifted its focus from treating type 2 diabetes to helping former GLP-1 users maintain their weight loss with Revita, an outpatient endoscopic procedure designed to target the root causes of metabolic disease in the duodenum. He also shares new clinical data, the strategy behind Fractyl's pivotal trial, the company's commercialization plans, and why he believes metabolic endoscopy could become an entirely new category of care. This episode is brought to you by the  DeviceTalks Interventional Innovations series, July 28-30th. To register for this complimentary series, click here. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:35) - Keynote Interview - Harith Rajagopalan, MD, PhD, Co-Founder and Chief Executive Officer, Fractyl Health(00:06:26) - Starting with Back of the Napkin Idea(00:18:45) - Why patients are enthusiastic(00:24:35) - The Parallels to Renal Denervation(00:29:40) - Commercial Plans, Pivotal Trials & What's Next

    Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

  6. 7月17日

    Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

    In this episode of the DeviceTalks Weekly Podcast, Managing Editor Kayleen Brown sits down with Johnson & Johnson MedTech Heart Recovery Worldwide President Devi Govender at DeviceTalks Boston. Govender shares how a deeply personal family experience shaped her mission to transform cardiovascular care. She reflects on Abiomed's integration into Johnson & Johnson, the evolution of heart recovery therapies, and why the industry must shift its mindset from treating "heart failure" to enabling "heart recovery." The discussion explores patient-centered innovation, AI, clinical evidence, and the power of combining technologies, data, and advocacy to redefine the future of cardiovascular care for patients around the world. This episode is sponsored by  Freudenberg Medical. Listen for a conversation with Shane Healy, Senior Director of Technology. Visit FreudenbergMedical.com for more information. We'll kick off this episode with Newmarker's Newsmakers. Host Tom Salemi and MassDevice Editor Chris Newmarker revisit the top MedTech stories of the week: Zeta Surgical, Hologic, Medtronic, Fractyl Health, and Vicarious Surgical. --- Enjoy the show? Follow DeviceTalks Weekly on all major podcast platforms, and subscribe to YouTube.com/@DeviceTalks so you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Subscribe today at [https://devicetalks.castos.com/subscribe](https://devicetalks.castos.com/subscribe). Chapters (00:09:10) - Zeta wins FDA clearance for TMS robotic stereotactic system(00:13:01) - Private equity firms reportedly set $4B price on Hologic Surgical unit(00:15:03) - Medtronic, FDA pick up legal victories in spinal cord stimulator suits(00:16:20) - Fractyl Health says its single-catheter treatment maintained most GLP-1 weight loss(00:22:17) - Vicarious Surgical's board wants to shut down and liquidate the robotics developer

    Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

  7. 7月10日

    Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

    In this episode of DeviceTalks Weekly, Host Tom explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. The conversation goes well beyond robotics. Fonseca explains why XCATH hires for humility as much as talent, how a culture of relentless experimentation and "carefrontation" fuels innovation, and why great MedTech companies are built by teams, not lone geniuses.  You'll also hear the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday."  Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal.  MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech.  ***  Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.  Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:36) - FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes(00:12:50) - Resmed to sell MatrixCare software business to private equity firm for $490M/ GTCR to divest Biosurgery unit of Corza Medical(00:15:58) - Medtronic’s chief sustainability officer is departing(00:17:55) - Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences(00:19:56) - Johnson & Johnson wins FDA approval for ThermoCool SmartTouch dual-energy ablation system

    Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

  8. 6月26日

    Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse

    In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal. Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO. Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In this week's FOMO interview, HistoSonics President and CEO Mike Blue speaks with MassDevice Editor Chris Newmarker during a keynote conversation at DeviceTalks Minnesota. In this excerpt, Blue reflects on the company's first major fundraising round, which attracted high-profile investors including Jeff Bezos and Peter Thiel, and shares his perspective on just how large the opportunity for histotripsy could become. But first, Tom and Jim Hammerand, managing editor of Medical Design & Outsourcing, discuss AI—or LLMs, or whatever term you prefer. Is the hype beginning to fade? And what should the industry make of the recent announcement from Midjourney Medical? *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - AI Talk with Jim Hammerand, managing editor, Medical Design & Outsourcing(00:24:46) - DeviceTalks Minnesota interview excerpt - Mike Blue, CEO and President, Histosonics(00:41:44) - Keynote Interview with Joe Catanese, CEO and President, Calyxo

    Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse
すべて見る（302）

番組について

Hosted by Tom Salemi, DeviceTalks Weekly is the foundational podcast for the entire DeviceTalks Podcast Network. The series delivers weekly news, insights, and commentary from MedTech industry leaders, keeping the medical device industry in the know and inspiring medical technology professionals to build better MedTech devices and companies.

情報

  • クリエイター
    DeviceTalks Podcast Network
  • 配信期間
    25年 - 26年
  • エピソード
    302
  • 制限指定
    不適切な内容を含まない
  • Copyright
    © 2025
  • 番組のWebサイト
    DeviceTalks Weekly

その他のおすすめ